Callan Family Office’s iShares Russell Mid-Cap Growth ETF IWP Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.12M Sell
7,630
-262
-3% -$36.1K 0.02% 568
2026
Q1
$1.01M Sell
7,892
-360
-4% -$48.7K 0.02% 552
2025
Q4
$1.13M Buy
8,252
+82
+1% +$11.5K 0.02% 518
2025
Q3
$1.16M Buy
8,170
+313
+4% +$44.2K 0.04% 352
2025
Q2
$1.09M Sell
7,857
-229
-3% -$29K 0.03% 377
2025
Q1
$950K Buy
8,086
+9
+0.1% +$1.16K 0.07% 221
2024
Q4
$1.02M Sell
8,077
-37
-0.5% -$4.7K 0.07% 249
2024
Q3
$952K Buy
8,114
+1,531
+23% +$171K 0.16% 71
2024
Q2
$726K Buy
6,583
+1,716
+35% +$189K 0.14% 70
2024
Q1
$556K Buy
4,867
+234
+5% +$25.3K 0.13% 58
2023
Q4
$484K Hold
4,633
0.12% 58
2023
Q3
$423K Hold
4,633
0.11% 58
2023
Q2
$448K Hold
4,633
0.12% 66
2023
Q1
$422K Buy
+4,633
New +$413K 0.1% 103

Other funds holding IWP

Callan Family Office's IWP Position: Q2 2026 in Review

Callan Family Office reduced its iShares Russell Mid-Cap Growth ETF (IWP) stake by 3.3% in Q2 2026, selling an estimated $36.1K and leaving 7,630 shares worth $1.12M. The position accounts for 0.02% of the portfolio, ranked #568.

Callan Family Office first reported a position in IWP in Q1 2023 and has held it in 14 quarters since. The position peaked at $1.16M in Q3 2025. 1,214 funds tracked by Wall St. Rank hold IWP as of Q2 2026.

  • Callan Family Office held 7,630 shares of iShares Russell Mid-Cap Growth ETF worth $1.12M as of Q2 2026.
  • Callan Family Office sold 262 iShares Russell Mid-Cap Growth ETF shares in Q2 2026, an estimated $36.1K.
  • iShares Russell Mid-Cap Growth ETF made up 0.02% of Callan Family Office's portfolio in Q2 2026, its #568 holding.
  • Callan Family Office first reported a position in iShares Russell Mid-Cap Growth ETF in Q1 2023 and has held it in 14 quarters since.
  • Callan Family Office's iShares Russell Mid-Cap Growth ETF position peaked at $1.16M in Q3 2025.
  • 1,214 funds tracked by Wall St. Rank held iShares Russell Mid-Cap Growth ETF as of Q2 2026.

Based on Callan Family Office's 13F filing for Q2 2026, filed 11 Aug 2026.